Home

Panorama Möglich Zusatz nf kappa b and mapk signaling hcc Proportional Ausprobieren unzureichend

The complexity of NF-κB signaling in inflammation and cancer | Molecular  Cancer | Full Text
The complexity of NF-κB signaling in inflammation and cancer | Molecular Cancer | Full Text

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical  study | Signal Transduction and Targeted Therapy
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy

Revealing the suppressive role of protein kinase C delta and p38  mitogen-activated protein kinase (MAPK)/NF-κB axis associates with  lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and  in vivo - ScienceDirect
Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo - ScienceDirect

Autophagy regulates IKK/NF-κΒ signaling in cancer cells. Autophagy... |  Download Scientific Diagram
Autophagy regulates IKK/NF-κΒ signaling in cancer cells. Autophagy... | Download Scientific Diagram

Cancers | Free Full-Text | MAPK/ERK Signaling Pathway in Hepatocellular  Carcinoma
Cancers | Free Full-Text | MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma

Frontiers | Inhibition of NF-κB Signaling Pathway by Resveratrol Improves  Spinal Cord Injury | Neuroscience
Frontiers | Inhibition of NF-κB Signaling Pathway by Resveratrol Improves Spinal Cord Injury | Neuroscience

Catalpol synergistically potentiates the anti-tumour effects of regorafenib  against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB  and VEGF/VEGFR2 signaling pathways | SpringerLink
Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways | SpringerLink

Cancers | Free Full-Text | STAT3: An Emerging Therapeutic Target for Hepatocellular  Carcinoma | HTML
Cancers | Free Full-Text | STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma | HTML

Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
Hepatocellular carcinoma: Mechanisms of progression and immunotherapy

The Nuclear Factor Kappa-B Signaling Pathway as a Therapeutic Target  Against Thyroid Cancers | Thyroid
The Nuclear Factor Kappa-B Signaling Pathway as a Therapeutic Target Against Thyroid Cancers | Thyroid

Critical signaling pathways governing hepatocellular carcinoma behavior;  small molecule-based approaches | Cancer Cell International | Full Text
Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches | Cancer Cell International | Full Text

The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic  implications - Delire - 2015 - European Journal of Clinical Investigation -  Wiley Online Library
The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications - Delire - 2015 - European Journal of Clinical Investigation - Wiley Online Library

NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma |  Nature Reviews Gastroenterology & Hepatology
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma | Nature Reviews Gastroenterology & Hepatology

Liquiritin inhibits proliferation and induces apoptosis in HepG2 hepatocellular  carcinoma cells via the ROS-mediated MAPK/AKT/NF-κB signaling pathway |  SpringerLink
Liquiritin inhibits proliferation and induces apoptosis in HepG2 hepatocellular carcinoma cells via the ROS-mediated MAPK/AKT/NF-κB signaling pathway | SpringerLink

A novel player in inflammation and cancer: The deubiquitinase CYLD controls  HCC development - Journal of Hepatology
A novel player in inflammation and cancer: The deubiquitinase CYLD controls HCC development - Journal of Hepatology

Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced  inflammation and cytotoxicity in H9c2 cardiac cells
Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells

Schematic representation of the MAPK and NF-κB pathway that are... |  Download Scientific Diagram
Schematic representation of the MAPK and NF-κB pathway that are... | Download Scientific Diagram

NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis

Current model of the role of stress-activated MAPK and NF-κB in... |  Download Scientific Diagram
Current model of the role of stress-activated MAPK and NF-κB in... | Download Scientific Diagram

Frontiers | Curcumin Regulates Cancer Progression: Focus on ncRNAs and  Molecular Signaling Pathways | Oncology
Frontiers | Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling Pathways | Oncology

The nuclear factor-kappa B pathway and response to treatment in breast  cancer | Pharmacogenomics
The nuclear factor-kappa B pathway and response to treatment in breast cancer | Pharmacogenomics

NF-κB Signaling | NF-kappaB Pathway
NF-κB Signaling | NF-kappaB Pathway

NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews  Immunology
NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews Immunology

The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in  human disorders - ScienceDirect
The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders - ScienceDirect

IJMS | Free Full-Text | Functional Roles of JNK and p38 MAPK Signaling in  Nasopharyngeal Carcinoma | HTML
IJMS | Free Full-Text | Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma | HTML

The nuclear factor-kappa B pathway and response to treatment in breast  cancer | Pharmacogenomics
The nuclear factor-kappa B pathway and response to treatment in breast cancer | Pharmacogenomics

Frontiers | IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular  Carcinoma | Oncology
Frontiers | IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma | Oncology

Interplay between HBx protein and PTEN. (1) HBx mediates upregulation... |  Download Scientific Diagram
Interplay between HBx protein and PTEN. (1) HBx mediates upregulation... | Download Scientific Diagram